Monthly Prescribing Reference

Epinephrine Nasal Spray Neffy Now Available to Treat Severe Allergic Reactions

Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...
Seeking Alpha

ARS Pharmaceuticals’ neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients ...

The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...
Nasdaq

ARS Pharmaceuticals Announces U.S. Availability of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis

Visit neffy.com to “Get neffy Now” and access the comprehensive patient assistance programs available through neffyConnect ARS Pharmaceuticals has also submitted a supplemental New Drug Application ...
Nasdaq

neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)

neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...
Healio

Dry powder epinephrine nasal spray outcomes comparable with intramuscular injection

Please provide your email address to receive an email when new articles are posted on . Subjects had two doses each of Belhaven Biopharma’s BBP01 and intramuscular epinephrine. Subjects had faster and ...
Healio

Survey reports epinephrine nasal spray’s real-world efficacy, ease of use

Please provide your email address to receive an email when new articles are posted on . The FDA approval was based on pharmacokinetic and pharmacodynamic data. The 375 health care providers surveyed ...
Trade Arabia

UAE approves nasal epinephrine spray for severe allergic reaction

The Emirates Drug Establishment (EDE) has officially granted approval for EURneffy, a novel epinephrine-based treatment ...
Yahoo Finance

neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The American Journal of Managed Care

Nasal Epinephrine Spray Appears Safe, Effective in CSU

Intranasal epinephrine was developed to provide needle-free, on-demand rescue therapy for CSU flares, addressing limitations of systemic options such as glucocorticoids and their adverse-effect burden ...
Medscape

Epinephrine Nasal Spray Promising for Urticaria Flares

Intranasal epinephrine spray ARS-2 may offer a safe and effective needle-free treatment alternative for chronic spontaneous urticaria, results from a phase 2 study suggested. Epinephrine has been used ...
Seeking Alpha

ARS Pharmaceuticals Announces U.S. Availability of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis

In addition to its U.S. launch, ARS Pharmaceuticals plans to expand access to EURneffy ® (trade name for neffy in the EU) internationally in partnership with an EU-based pharmaceutical partner. On ...
The Manila Times

neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

Canada for adults and children (>30 kg) living with severe allergic reactions ALK- Abelló A/S, which licenses the rights to ...